Cargando…
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology
INTRODUCTION: Currently, none of the available multiple sclerosis (MS) disease-modifying medications has been shown to stop or reverse gait disability. Recently, the nabiximols has been tested for the treatment of spasticity and walking impairment in MS. Nabiximols (trade name Sativex) is an oromuco...
Autores principales: | Russo, Margherita, Dattola, Vincenzo, Logiudice, Anna Lisa, Ciurleo, Rosella, Sessa, Edoardo, De Luca, Rosaria, Bramanti, Placido, Bramanti, Alessia, Naro, Antonino, Calabrò, Rocco Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704890/ https://www.ncbi.nlm.nih.gov/pubmed/29145345 http://dx.doi.org/10.1097/MD.0000000000008826 |
Ejemplares similares
-
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
por: Russo, Margherita, et al.
Publicado: (2015) -
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
por: Russo, Margherita, et al.
Publicado: (2015) -
Does body shadow improve the efficacy of virtual reality-based training with BTS NIRVANA?: A pilot study
por: Russo, Margherita, et al.
Publicado: (2017) -
Acute exacerbation of Hashimoto's thyroiditis in a patient treated with dimethyl fumarate for multiple sclerosis: A case report
por: Ciurleo, Rosella, et al.
Publicado: (2019) -
Chronic inflammatory demyelinating polyradiculoneuropathy relapse after mexiletine withdrawal in a patient with concomitant myotonia congenita: A case report on a potential treatment option
por: Portaro, Simona, et al.
Publicado: (2020)